Markel Co. (NYSE:MKL) insider Alan I. Kirshner sold 100 shares of the firm’s stock in a transaction that occurred on Monday, April 2nd. The stock was sold at an average price of $1,149.02, for a total transaction of $114,902.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
NYSE MKL opened at $1,148.16 on Friday. The company has a market cap of $16,142.14, a PE ratio of 2,002.12 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.60 and a quick ratio of 0.60. Markel Co. has a 1-year low of $936.95 and a 1-year high of $1,194.98.
Markel (NYSE:MKL) last issued its quarterly earnings results on Tuesday, February 6th. The insurance provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $8.55 by ($1.91). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.58 billion. Markel had a net margin of 6.52% and a return on equity of 0.39%. equities analysts predict that Markel Co. will post 36.87 earnings per share for the current year.
Several research firms have recently weighed in on MKL. ValuEngine raised shares of Markel from a “sell” rating to a “hold” rating in a report on Monday, April 2nd. SunTrust Banks raised their price objective on shares of Markel to $1,200.00 and gave the stock a “hold” rating in a report on Thursday, February 8th. Zacks Investment Research lowered shares of Markel from a “buy” rating to a “hold” rating in a report on Thursday, January 11th. Royal Bank of Canada reaffirmed a “hold” rating and set a $1,200.00 price objective on shares of Markel in a report on Thursday, February 8th. Finally, William Blair raised shares of Markel from a “market perform” rating to an “outperform” rating in a report on Monday, March 19th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $1,172.00.
Several institutional investors have recently modified their holdings of MKL. Aevitas Wealth Management Inc. acquired a new stake in shares of Markel in the fourth quarter valued at approximately $108,000. First Personal Financial Services increased its holdings in shares of Markel by 156.1% in the fourth quarter. First Personal Financial Services now owns 105 shares of the insurance provider’s stock valued at $120,000 after purchasing an additional 64 shares in the last quarter. SeaCrest Wealth Management LLC acquired a new stake in shares of Markel in the fourth quarter valued at approximately $122,000. Simplex Trading LLC increased its holdings in shares of Markel by 169.1% in the fourth quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock valued at $168,000 after purchasing an additional 93 shares in the last quarter. Finally, Cigna Investments Inc. New acquired a new stake in shares of Markel in the fourth quarter valued at approximately $201,000. 78.15% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/07/alan-i-kirshner-sells-100-shares-of-markel-co-mkl-stock.html.
Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.